The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their romantic partners. All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their partners will attend 2 of those sessions with them.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. Partners will attend 2 of the 7 treatment sessions. During the sessions, participants will learn techniques for managing and changing nightmares.
University of Utah
Salt Lake City, Utah, United States
RECRUITINGDisturbing Dream and Nightmare Severity Index (DDNSI)
The DDNSI is a questionnaire which measures the severity of nightmares.
Time frame: Baseline and posttreatment
Nightmare frequency (sleep diary)
The number of nightmares experienced each day will be collected on daily sleep diaries completed during each assessment period.
Time frame: Baseline and posttreatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.